S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

ALLR Allarity Therapeutics Inc

1.40

0.08 (6.06%)

Jan 24 2025 - Closed

Delayed by 15 minutes

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Allarity Therapeutics (NASDAQ:ALLR)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Allarity Therapeutics Charts.

Allarity Therapeutics (NASDAQ:ALLR)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Allarity Therapeutics Charts.

Allarity Therapeutics Inc News

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Friday 24 January 2025 (2 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 24 January 2025 (2 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 24 January 2025 (2 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 24 January 2025 (2 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 24 January 2025 (2 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 19 November 2024 (2 months ago) • Edgar (US Regulatory)

Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements
Monday 18 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Allarity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Recent Operational Highlights
Thursday 14 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 23 October 2024 (3 months ago) • Edgar (US Regulatory)

Allarity Therapeutics to be Granted European Patent for DRP® Companion Diagnostic for Stenoparib
Tuesday 22 October 2024 (3 months ago) • GlobeNewswire Inc.

More Allarity Therapeutics Inc News Articles

TransCode Therapeutics

MineralRite (PK)

Kraig Biocraft Laborator... (QB)

NioCorp Developments

Bioelectronics (PK)

TheGlobe com (PK)

Elite Pharmaceuticals (QB)

Fannie Mae (QB)

Anavex Life Sciences

Northwest Biotherapeutics (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions